You are currently viewing a new version of our website. To view the old version click .

Combination Therapy Approaches for Cancer Treatment

Special Issue Information

Dear Colleagues,

We are pleased to invite you to contribute to a Special Issue on “Combination therapy approaches for cancer treatment”. The treatment of human malignancies invites ongoing challenges, including the development of tumor resistance mechanisms to conventional therapeutic agents. Thus, combination therapy approaches are being explored to target tumor resistance mechanisms and counter-regulatory pathways involved in impeding the efficacy of cancer therapies to improve the overall responses of therapeutic agents, including survival benefits.

This Special Issue aims to publish original research articles or reviews on combination therapy approaches for cancer treatment, which fits with the journal’s scope regarding drug targeting and interdisciplinary research, involving, but not limited to, biomedical sciences and cell biology.

In this Special Issue, research areas may include (but are not limited to) the following: a combination of chemotherapeutic agents, repurposed drugs, dietary phytochemicals, targeted therapy, and immunotherapy approaches on any cancer models.

We look forward to receiving your contributions

Dr. Ravi P. Sahu
Dr. Anita Thyagarajan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • combination therapy approaches
  • cancer chemoprevention
  • chemotherapeutic agents
  • cell signaling pathways
  • dietary phytochemicals
  • tumor resistance mechanisms
  • repurposed drugs
  • targeted therapy
  • immunotherapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers